Richiedi una copia del documento: Predictors Of Pathologic Response To Trastuzumab-Based Neoadjuvant Treatment In A Consecutive Monoinstitutional Series Of Breast Carcinomas Tested With Frontline Dual-Color HER2 FISH

Captcha code
Annulla